Websites targeting keyword severe asthma

The XOLAIR Co-pay Card Program can help you with your co-pay for XOLAIR, a treatment for appropriate moderate to severe persistent allergic asthma patients.

Introducing NUCALA, an add-on maintenance treatment for patients with severe asthma aged 12 years and older with an eosinophilic phenotype.

Is your severe asthma e-asthma? Read about e-asthma (eosinophilic asthma) and find out more about severe asthma and eosinophils.

“Well, there’s one story I tell to help people understand intersectionality: There’s a picture I show of this young boy named Antoine, who lives in Indiantown, Florida, 3 miles from a coal-fired power plant. He has severe asthma. There’s a picture of his bag of medicines that show what he depends on to get by…

XOLAIR® (omalizumab) is a treatment for moderate to severe persistent allergic asthma and Chronic Idiopathic Urticaria (CIU) in appropriate patients.

CINQAIR® (reslizumab) Injection is now approved as an add-on treatment for adults (18 years and older) with severe asthma and elevated eosinophil levels